Boeing Co is close to selling dozens of its 737 MAX 7 jets to Southwest Airlines Co, that includes potentially "significant options."
Each 737 MAX 7has a listed price of around $100 million, though it sells for less than half of that with typical market discounts.
Southwest Chief Executive Gary Kelly said in November that the company was debating between the Boeing 737 MAX-7, which has yet to be certified, or the A220, which would mean a shift away from its all-Boeing fleet for the first time.
While acknowledging that the A220 is “a great plane,” Kelly reiterated the advantages to having a single fleet type.
In December, Alaska Airlines agreed to buy 23 737 MAX 9 jets after Ryanair ordered 75.
The MAX 7, the smallest of four MAX variants, has 153 seats in a two-class configuration and a range of 3,850 nautical miles.
Boeing’s overall order backlog stood at 4,041 aircraft as of end-February.
The 737 MAX family has been grounded for nearly two years following its fatal crashes with Lion Air in 2018 and Ethiopian Airlines in 2019 when 346 people died.


Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S. 



